Andrzej Dlugosz, MD
Poth Professor of Cutaneous Oncology
Associate Chair, Department of Dermatology
Professor of Dermatology
Professor of Cell and Developmental Biology
[email protected]

Available to mentor
Andrzej Dlugosz, MD
Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • MD
      Pennsylvania State University College of Medicine, USA
    Center Memberships
    • Center Member
      Center for Cell Plasticity and Organ Design
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Development of a Multiplex Immunofluorescence Assay for Tumor Microenvironment Studies of Human and Murine Merkel Cell Carcinoma.
      Sun L, Verhaegen ME, McGue J, Olivei AC, Dlugosz AA, Frankel TL, Harms PW. Lab Invest, 2024 Oct; 104 (10): 102128 DOI:10.1016/j.labinv.2024.102128
      PMID: 39182611
    • Journal Article
      Corrigendum to "Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma" [Neoplasia, Volume 21, Issue 3 (2019) 322-330].
      Choi JE, Verhaegen ME, Yazdani S, Malik R, Harms PW, Mangelberger D, Tien J, Cao X, Wang Y, Cieślik M, Gurkan J, Yazdani M, Jing X, Juckette K, Su F, Wang R, Zhou B, Apel IJ, Wang S, Dlugosz AA, Chinnaiyan AM. Neoplasia, 2024 Sep; 55: 101019 DOI:10.1016/j.neo.2024.101019
      PMID: 38943995
    • Journal Article
      Identification of Meibomian gland stem cell populations and mechanisms of aging.
      Zhu X, Xu M, Portal C, Lin Y, Ferdinand A, Peng T, Morrisey EE, Dlugosz AA, Castellano JM, Lee V, Seykora JT, Iomini C, Millar SE. bioRxiv, 2024 Aug 10; DOI:10.1101/2024.08.09.607015
      PMID: 39149265
    • Proceeding / Abstract / Poster
      016 Investigating therapeutic targeting of the female-biased factor VGLL3 in lupus
      van Drongelen V, Young K, Gharaee-Kermani M, Plazyo O, Griffin E, Syu L, Xing E, Ward NL, Tsoi LC, Kahlenberg M, Dlugosz A, Gudjonsson JE, Billi A. Journal of Investigative Dermatology, 2024 May; 144 (8): s3 - s3. DOI:10.1016/j.jid.2024.06.032
    • Journal Article
      838 Immunotherapy-responsive preclinical model of Merkel cell carcinoma in immune-competent mice
      Verhaegen M, Singer K, Wilbert D, Moore A, Baumbick M, Walter E, Harms PW, Dlugosz A. Journal of Investigative Dermatology, 2024 Aug; 144 (8): s146 DOI:10.1016/j.jid.2024.06.854
    • Journal Article
      A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variants.
      Meyer-Schuman R, Cale AR, Pierluissi JA, Jonatzke KE, Park YN, Lenk GM, Oprescu SN, Grachtchouk MA, Dlugosz AA, Beg AA, Meisler MH, Antonellis A. HGG Adv, 2024 Jul 18; 5 (3): 100324 DOI:10.1016/j.xhgg.2024.100324
      PMID: 38956874
    • Journal Article
      Corrigendum to "Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma" [Neoplasia, Volume 21, Issue 3 (2019) 322-330].
      Choi JE, Verhaegen ME, Yazdani S, Malik R, Harms PW, Mangelberger D, Tien J, Cao X, Wang Y, Cieślik M, Gurkan J, Yazdani M, Jing X, Juckette K, Su F, Wang R, Zhou B, Apel IJ, Wang S, Dlugosz AA, Chinnaiyan AM. Neoplasia, 2024 May; 51: 100995 DOI:10.1016/j.neo.2024.100995
      PMID: 38574506
    • Preprint
      Predictive modeling provides insight into the clinical heterogeneity associated with TARS1 loss-of-function mutations.
      Meyer-Schuman R, Cale AR, Pierluissi JA, Jonatzke KE, Park YN, Lenk GM, Oprescu SN, Grachtchouk MA, Dlugosz AA, Beg AA, Meisler MH, Antonellis A. 2024 Mar 27; DOI:10.1101/2024.03.25.586600
      PMID: 38585737